CCR Clinical Trials at NIH: Clinical Research: Search for Clinical Trials at NIH

The NCI Center for Cancer Research (CCR) conducts more than 150 cancer clinical trials at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Cancer clinical trials that take place at the NIH Clinical Center are open to patients with cancer, regardless of where they live in the United States.

Go to Search Page

There are 11 clinical trials at NIH that match your search criteria

Cancer by body location/system: Breast Cancer

Trial and Protocol Number Breast Cancer	Principal Investigator	Referral Contact
A Phase I, Open-Label Study of MEDI-547 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biologic Activity of Intravenous Administration in Subjects With Refractory Solid Tumors Associated With EphA2 Expression NCI-09-C-0168	Elise C. Kohn 301-402-2726	Laura D. Otten 301-451-1228 1-866-611-6310 (Toll Free) ottenl@mail.nih.gov
A Natural History Study of Patients Receiving High Dose Rate Brachytherapy NCI-09-C-0100	Aradhana Kaushal 301-496-5457	Sharon L. Smith 301-496-5457 smiths@mail.nih.gov
The Natural History of Solid Organ Cancer Stem Cells NCI-09-C-0079	Itzhak Avital 301-402-0083	Melissa Walker 301-402-9537 walkerme@mail.nih.gov
A Phase I Study With an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined With Carboplatin in Breast and Ovarian Cancer in BRCA 1/2 Mutation Carriers and Familial Breast and Ovarian Cancer NCI-08-C-0092	Elise C. Kohn 301-402-2726	Laura D. Otten 301-451-1228 1-866-611-6310 (Toll Free) ottenl@mail.nih.gov
A Phase 0 Trial of [111] Indium CHX-A" DTPA Trastuzumab Imaging in Cancer NCI-07-C-0101	Peter Choyke 301-451-4220	Yolanda McKinney 301-443-6913 ymckinney@mail.nih.gov
A Phase I Trial of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine in Advanced Malignancies NCI-06-C-0221	James Doroshow 301-496-4291	Janelle Bingham 301-435-2715 jbingham@mail.nih.gov
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Patients With Metastatic Breast Cancer NCI-05-C-0229	James L. Gulley 301-435-2956	Laura D. Otten 301-451-1228 1-866-611-6310 (Toll Free) ottenl@mail.nih.gov
A Phase I-II Study of Tumor Vaccine Following Chemotherapy in Patients With Metastatic Breast Cancer Untreated With Chemo/Radiation in the Previous 18 Months: Vaccine-Induced Bias of T-Cell Repertoire Reconstitution After T-Cell Re-Infusion NCI-03-C-0040	Claude Sportés 301-435-5280	Zetta Blacklock 301-594-2056 bblacklock@mail.nih.gov
Clinical, Genetic, Behavioral, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer NCI-02-C-0212	Phuong Mai 301-496-9928	Stephanie Steinbart 1-800-518-8474 (Toll Free)
Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile NCI-02-C-0077	David N. Danforth 301-496-1533
A Phase I Investigation of IL-12/Pulse IL-2 in Adults With Advanced Solid Tumors NCI-00-C-0121	John E. Janik 301-402-2913	Debbie Draper 301-435-8525 draperde@mail.nih.gov

For additional studies that may be appropriate for your disease type, please search under Solid Tumor.